View in EDS HTML Full Text PDF Full Text

Progress and promise for the MDMA drug development program.

Saved in:
Bibliographic Details
Title: Progress and promise for the MDMA drug development program.
Authors: Feduccia AA; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, 95060, USA. alli@mapsbcorp.com., Holland J; Private Practice, New York, New York, 10016, USA., Mithoefer MC; Medical University of South Carolina, 96 Jonathan Lucas St, Charleston, SC, 29425, USA.
Source: Psychopharmacology [Psychopharmacology (Berl)] 2018 Feb; Vol. 235 (2), pp. 561-571. Date of Electronic Publication: 2017 Nov 20.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29152674
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Progress and promise for the MDMA drug development program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Feduccia+AA%22">Feduccia AA</searchLink>; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, 95060, USA. alli@mapsbcorp.com.<br /><searchLink fieldCode="AU" term="%22Holland+J%22">Holland J</searchLink>; Private Practice, New York, New York, 10016, USA.<br /><searchLink fieldCode="AU" term="%22Mithoefer+MC%22">Mithoefer MC</searchLink>; Medical University of South Carolina, 96 Jonathan Lucas St, Charleston, SC, 29425, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227608025%22">Psychopharmacology</searchLink> [Psychopharmacology (Berl)] 2018 Feb; Vol. 235 (2), pp. 561-571. <i>Date of Electronic Publication: </i>2017 Nov 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7608025 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-2072 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200333158%22">00333158 </searchLink><i>NLM ISO Abbreviation: </i>Psychopharmacology (Berl) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29152674
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00213-017-4779-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 561
    Titles:
      – TitleFull: Progress and promise for the MDMA drug development program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feduccia AA
      – PersonEntity:
          Name:
            NameFull: Holland J
      – PersonEntity:
          Name:
            NameFull: Mithoefer MC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2018 Feb
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1432-2072
          Numbering:
            – Type: volume
              Value: 235
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Psychopharmacology
              Type: main
ResultId 1